Hammerson PLC

Director's Dealing • May 9, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5494Y

Hammerson PLC

09 May 2019

Hammerson plc (the 'Company')

Notification of Transaction of Director

9 May 2019

The Company was notified on 9 May 2019 that Andrew Formica, a Director of the Company, has acquired 22,000 ordinary shares of 25 pence each at a price of £2.89595 per share.

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation. The notification of dealing form can be formed below.

Note: the announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

Julia Crane

Deputy Company Secretary

Notification of dealing form

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Andrew Formica

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer

a)

Name

Hammerson plc

b)

LEI

213800G1C9KKVVDN1A60

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument.

Identification code

Ordinary shares of 25 pence each

ISIN: GB0004065016

b)

Nature of the transaction

Purchase of ordinary shares of 25 pence

c)

Price(s) and volume(s)

	Price(s)	Volume(s)
	£2.89595	22,000

d)

Aggregated information

-     Aggregated volume

-     Price

	Aggregate Price	Aggregate Volume	Aggregate Total
	£2.89595	22,000	£63,710.90

e)

Date of the transaction

9 May 2019

f)

Place of the transaction

XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEAFSNESFNEFF